List of Tables
Table 1. Global Oclacitinib Sales (Kg) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Oclacitinib Sales (Kg) Comparison by Application: 2020 VS 2026
Table 3. Global Oclacitinib Market Size by Type (Kg) (US$ Million) (2020 VS 2026)
Table 4. Global Key Oclacitinib Manufacturers Covered in This Study
Table 5. Global Oclacitinib Sales (Kg) by Manufacturers (2015-2020)
Table 6. Global Oclacitinib Sales Share by Manufacturers (2015-2020)
Table 7. Global Oclacitinib Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Oclacitinib Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Oclacitinib Average Price (K USD/Kg) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Oclacitinib Sales Sites and Area Served
Table 11. Manufacturers Oclacitinib Product Types
Table 12. Global Oclacitinib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Oclacitinib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oclacitinib as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Oclacitinib Players
Table 16. Global Oclacitinib Sales (Kg) by Region (2015-2020)
Table 17. Global Oclacitinib Sales Market Share by Region (2015-2020)
Table 18. Global Oclacitinib Revenue (Million US$) by Region (2015-2020)
Table 19. Global Oclacitinib Revenue Market Share by Region (2015-2020)
Table 20. North America Oclacitinib Sales by Country (2015-2020) (Kg)
Table 21. North America Oclacitinib Sales Market Share by Country (2015-2020)
Table 22. North America Oclacitinib Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Oclacitinib Revenue Market Share by Country (2015-2020)
Table 24. Europe Oclacitinib Sales by Country (2015-2020) (Kg)
Table 25. Europe Oclacitinib Sales Market Share by Country (2015-2020)
Table 26. Europe Oclacitinib Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Oclacitinib Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Oclacitinib Sales by Region (2015-2020) (Kg)
Table 29. Asia Pacific Oclacitinib Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Oclacitinib Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Oclacitinib Revenue Market Share by Region (2015-2020)
Table 32. Latin America Oclacitinib Sales by Country (2015-2020) (Kg)
Table 33. Latin America Oclacitinib Sales Market Share by Country (2015-2020)
Table 34. Latin America Oclacitinib Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Oclacitinib Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Oclacitinib Sales by Country (2015-2020) (Kg)
Table 37. Middle East and Africa Oclacitinib Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Oclacitinib Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Oclacitinib Revenue Market Share by Country (2015-2020)
Table 40. Global Oclacitinib Sales (Kg) by Type (2015-2020)
Table 41. Global Oclacitinib Sales Share by Type (2015-2020)
Table 42. Global Oclacitinib Revenue (Million US$) by Type (2015-2020)
Table 43. Global Oclacitinib Revenue Share by Type (2015-2020)
Table 44. Global Oclacitinib Price (K USD/Kg) by Type (2015-2020)
Table 45. Global Oclacitinib Sales (Kg) by Application (2015-2020)
Table 46. Global Oclacitinib Sales Market Share by Application (2015-2020)
Table 47. Global Oclacitinib Sales Growth Rate by Application (2015-2020)
Table 48. Cayman Chemical Corporation Information
Table 49. Cayman Chemical Description and Business Overview
Table 50. Cayman Chemical Oclacitinib Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 51. Cayman Chemical Main Product
Table 52. Cayman Chemical Recent Development
Table 53. Toronto Research Chemicals Corporation Information
Table 54. Toronto Research Chemicals Description and Business Overview
Table 55. Toronto Research Chemicals Oclacitinib Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 56. Toronto Research Chemicals Main Product
Table 57. Toronto Research Chemicals Recent Development
Table 58. Taiclone Corporation Information
Table 59. Taiclone Description and Business Overview
Table 60. Taiclone Oclacitinib Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 61. Taiclone Main Product
Table 62. Taiclone Recent Development
Table 63. BioVision Corporation Information
Table 64. BioVision Description and Business Overview
Table 65. BioVision Oclacitinib Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 66. BioVision Main Product
Table 67. BioVision Recent Development
Table 68. Adooq Bioscience Corporation Information
Table 69. Adooq Bioscience Description and Business Overview
Table 70. Adooq Bioscience Oclacitinib Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 71. Adooq Bioscience Main Product
Table 72. Adooq Bioscience Recent Development
Table 73. APExBIO Technology Corporation Information
Table 74. APExBIO Technology Description and Business Overview
Table 75. APExBIO Technology Oclacitinib Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 76. APExBIO Technology Main Product
Table 77. APExBIO Technology Recent Development
Table 78. BOC Sciences Corporation Information
Table 79. BOC Sciences Description and Business Overview
Table 80. BOC Sciences Oclacitinib Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 81. BOC Sciences Main Product
Table 82. BOC Sciences Recent Development
Table 83. TargetMol Corporation Information
Table 84. TargetMol Description and Business Overview
Table 85. TargetMol Oclacitinib Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 86. TargetMol Main Product
Table 87. TargetMol Recent Development
Table 88. BioVision Corporation Information
Table 89. BioVision Description and Business Overview
Table 90. BioVision Oclacitinib Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 91. BioVision Main Product
Table 92. BioVision Recent Development
Table 93. MyBiosource Corporation Information
Table 94. MyBiosource Description and Business Overview
Table 95. MyBiosource Oclacitinib Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 96. MyBiosource Main Product
Table 97. MyBiosource Recent Development
Table 98. Biosynth Carbosynth Corporation Information
Table 99. Biosynth Carbosynth Description and Business Overview
Table 100. Biosynth Carbosynth Oclacitinib Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 101. Biosynth Carbosynth Main Product
Table 102. Biosynth Carbosynth Recent Development
Table 103. Clearsynth Corporation Information
Table 104. Clearsynth Description and Business Overview
Table 105. Clearsynth Oclacitinib Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 106. Clearsynth Main Product
Table 107. Clearsynth Recent Development
Table 108. Selleck Chemicals Corporation Information
Table 109. Selleck Chemicals Description and Business Overview
Table 110. Selleck Chemicals Oclacitinib Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 111. Selleck Chemicals Main Product
Table 112. Selleck Chemicals Recent Development
Table 113. MedKoo Corporation Information
Table 114. MedKoo Description and Business Overview
Table 115. MedKoo Oclacitinib Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 116. MedKoo Main Product
Table 117. MedKoo Recent Development
Table 118. CSNpharm Corporation Information
Table 119. CSNpharm Description and Business Overview
Table 120. CSNpharm Oclacitinib Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 121. CSNpharm Main Product
Table 122. CSNpharm Recent Development
Table 123. LifeSpan BioSciences Corporation Information
Table 124. LifeSpan BioSciences Description and Business Overview
Table 125. LifeSpan BioSciences Oclacitinib Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 126. LifeSpan BioSciences Main Product
Table 127. LifeSpan BioSciences Recent Development
Table 128. J&K Scientific Corporation Information
Table 129. J&K Scientific Description and Business Overview
Table 130. J&K Scientific Oclacitinib Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 131. J&K Scientific Main Product
Table 132. J&K Scientific Recent Development
Table 133. Production Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. Oclacitinib Distributors List
Table 136. Oclacitinib Customers List
Table 137. Oclacitinib Market Trends
Table 138. Oclacitinib Opportunities and Drivers
Table 139. Oclacitinib Market Challenges
Table 140. Global Oclacitinib Sales (Kg) Forecast by Type (2021-2026)
Table 141. Global Oclacitinib Sales Market Share Forecast by Type (2021-2026)
Table 142. Global Oclacitinib Revenue (Million US$) Forecast by Type (2021-2026)
Table 143. Global Oclacitinib Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 144. Global Oclacitinib Sales (Kg) Forecast by Application (2021-2026)
Table 145. Global Oclacitinib Revenue (Million US$) Forecast by Application (2021-2026)
Table 146. Global Oclacitinib Sales (Kg) Forecast by Region (2021-2026)
Table 147. Global Oclacitinib Sales Market Share Forecast by Region (2021-2026)
Table 148. Global Oclacitinib Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Global Oclacitinib Revenue Market Share Forecast by Region (2021-2026)
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Oclacitinib
Figure 2. Global Oclacitinib Sales Market Share by Type: 2020 VS 2026
Figure 3. Min Purity Less Than 98% Product Picture
Figure 4. Min Purity 98%-99% Product Picture
Figure 5. Min Purity More Than 99% Product Picture
Figure 6. Global Oclacitinib Consumption Market Share by Application: 2020 VS 2026
Figure 7. Research
Figure 8. Medical
Figure 9. Global Oclacitinib Market Size 2015-2026 (US$ Million)
Figure 10. Global Oclacitinib Sales Capacity (Kg) (2015-2026)
Figure 11. Global Oclacitinib Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Oclacitinib Sales Share by Manufacturers in 2020
Figure 13. Global Oclacitinib Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Oclacitinib Revenue in 2019
Figure 15. Oclacitinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Oclacitinib Sales Market Share by Region (2015-2020)
Figure 17. Global Oclacitinib Sales Market Share by Region in 2019
Figure 18. Global Oclacitinib Revenue Market Share by Region (2015-2020)
Figure 19. Global Oclacitinib Revenue Market Share by Region in 2019
Figure 20. North America Oclacitinib Sales Market Share by Country in 2019
Figure 21. North America Oclacitinib Revenue Market Share by Country in 2019
Figure 22. U.S. Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 23. U.S. Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 25. Canada Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Oclacitinib Sales Market Share by Country in 2019
Figure 27. Europe Oclacitinib Revenue Market Share by Country in 2019
Figure 28. Germany Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 29. Germany Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 31. France Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 33. U.K. Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 35. Italy Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 37. Russia Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Oclacitinib Sales Market Share by Region in 2019
Figure 39. Asia Pacific Oclacitinib Revenue Market Share by Region in 2019
Figure 40. China Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 41. China Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 43. Japan Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 45. South Korea Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 47. India Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 49. Australia Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 51. Taiwan Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 53. Indonesia Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 55. Thailand Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 57. Malaysia Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 59. Philippines Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 61. Vietnam Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Oclacitinib Sales Market Share by Country in 2019
Figure 63. Latin America Oclacitinib Revenue Market Share by Country in 2019
Figure 64. Mexico Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 65. Mexico Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 67. Brazil Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 69. Argentina Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Oclacitinib Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Oclacitinib Revenue Market Share by Country in 2019
Figure 72. Turkey Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 73. Turkey Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 75. Saudi Arabia Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. UAE Oclacitinib Sales Growth Rate (2015-2020) (Kg)
Figure 77. UAE Oclacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Oclacitinib by Type (2015-2020)
Figure 79. Sales Market Share of Oclacitinib by Type in 2020
Figure 80. Global Oclacitinib Market Share by Price Range (2015-2020)
Figure 81. Revenue Market Share of Oclacitinib by Type in 2019
Figure 82. Global Oclacitinib Sales Growth by Type (2015-2020) (Kg)
Figure 83. Sales Market Share of Oclacitinib by Application (2015-2020)
Figure 84. Sales Market Share of Oclacitinib by Application in 2020
Figure 85. Revenue Share of Oclacitinib by Application (2015-2020)
Figure 86. Revenue Share of Oclacitinib by Application in 2020
Figure 87. Key Raw Materials Price Trend
Figure 88. Manufacturing Cost Structure of Oclacitinib
Figure 89. Manufacturing Process Analysis of Oclacitinib
Figure 90. Oclacitinib Industrial Chain Analysis
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Porter's Five Forces Analysis
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
